The ethics and economics of pharmaceutical pricing.
Annu Rev Pharmacol Toxicol. 2015.
PMID: 25149920
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1953 | 1 |
| 1971 | 1 |
| 1972 | 1 |
| 1973 | 1 |
| 1974 | 2 |
| 1975 | 3 |
| 1977 | 1 |
| 1978 | 1 |
| 1979 | 1 |
| 1981 | 1 |
| 1982 | 1 |
| 1983 | 1 |
| 1984 | 1 |
| 1985 | 3 |
| 1986 | 5 |
| 1987 | 5 |
| 1988 | 2 |
| 1989 | 3 |
| 1990 | 8 |
| 1991 | 15 |
| 1992 | 10 |
| 1993 | 12 |
| 1994 | 17 |
| 1995 | 15 |
| 1996 | 8 |
| 1997 | 13 |
| 1998 | 20 |
| 1999 | 26 |
| 2000 | 26 |
| 2001 | 24 |
| 2002 | 23 |
| 2003 | 37 |
| 2004 | 45 |
| 2005 | 27 |
| 2006 | 44 |
| 2007 | 35 |
| 2008 | 47 |
| 2009 | 53 |
| 2010 | 58 |
| 2011 | 35 |
| 2012 | 44 |
| 2013 | 47 |
| 2014 | 37 |
| 2015 | 28 |
| 2016 | 43 |
| 2017 | 75 |
| 2018 | 119 |
| 2019 | 69 |
| 2020 | 49 |
| 2021 | 42 |
| 2022 | 27 |
| 2023 | 23 |
| 2024 | 100 |
| 2025 | 351 |
| 2026 | 186 |
Search Results
1,737 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
The ethics and economics of pharmaceutical pricing.
Annu Rev Pharmacol Toxicol. 2015;55:191-206. doi: 10.1146/annurev-pharmtox-010814-124649. Epub 2014 Aug 13.
Annu Rev Pharmacol Toxicol. 2015.
PMID: 25149920
Review.
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices and find that advances in economic research have increase …
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics …
Pharmaceutical promotions and conflict of interest in nurse practitioner's decision making: the undiscovered country.
J Am Acad Nurse Pract. 2005 Jun;17(6):207-12. doi: 10.1111/j.1041-2972.2005.00034.x.
J Am Acad Nurse Pract. 2005.
PMID: 15924562
Review.
PURPOSE: To increase nurse practitioners' (NPs) awareness of the conflict of interest that exists between the NPs' primary goal of making the best medication choices for patients and the potentially negative impact that the pharmaceutical industry's marketing strategies ha …
PURPOSE: To increase nurse practitioners' (NPs) awareness of the conflict of interest that exists between the NPs' primary goal of making th …
Kaleidoscope.
AMA J Ethics. 2018 Sep 1;20(9):E894-896. doi: 10.1001/amajethics.2018.894.
AMA J Ethics. 2018.
PMID: 30242822
Free article.
The photograph also suggests the importance of several ethical questions....
The photograph also suggests the importance of several ethical questions....
Alternative Medicine and the Ethics Of Commerce.
Bioethics. 2016 Feb;30(2):77-84. doi: 10.1111/bioe.12226.
Bioethics. 2016.
PMID: 26806450
Is it ethical to market complementary and alternative medicines? Complementary and alternative medicines (CAM) are medical products and services outside the mainstream of medical practice. ...This article aims instead to consider CAM from the perspective of commercial e …
Is it ethical to market complementary and alternative medicines? Complementary and alternative medicines (CAM) are medical products a …
Medical ethics, research and the pharmaceutical industry.
Reumatol Clin. 2012 Sep-Oct;8(5):233-5. doi: 10.1016/j.reuma.2011.12.010. Epub 2012 May 17.
Reumatol Clin. 2012.
PMID: 22608694
Free article.
No abstract available.
Pharmaceutical patenting and the transformation of American medical ethics.
Br J Hist Sci. 2016 Dec;49(4):577-600. doi: 10.1017/S0007087416001138. Epub 2016 Nov 24.
Br J Hist Sci. 2016.
PMID: 27881189
The attitudes of physicians and drug manufacturers in the US toward patenting pharmaceuticals changed dramatically from the mid-nineteenth century to the mid-twentieth. ...Shifts in wider patenting cultures therefore transformed the ethical sensibilities of physicia …
The attitudes of physicians and drug manufacturers in the US toward patenting pharmaceuticals changed dramatically from the mid-ninet …
Medicine and the pharmaceutical industry.
Dev Med Child Neurol. 2006 Aug;48(8):627. doi: 10.1017/S0012162206001320.
Dev Med Child Neurol. 2006.
PMID: 16836771
Free article.
No abstract available.
Filling in the Gaps: Priming and the Ethics of Pharmaceutical Advertising.
Kennedy Inst Ethics J. 2015 Jun;25(2):193-230. doi: 10.1353/ken.2015.0008.
Kennedy Inst Ethics J. 2015.
PMID: 26144539
I build a case that Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) operates as a prime that causes some viewers to prefer and pursue the advertised drug. ...
I build a case that Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA) operates as a prime that causes some viewer …
Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Child Adolesc Psychiatr Clin N Am. 2008 Jan;17(1):113-25, ix-x. doi: 10.1016/j.chc.2007.07.007.
Child Adolesc Psychiatr Clin N Am. 2008.
PMID: 18036482
Review.
Health care in the United States is a tangled web of competing interest groups beneath which ethical conflicts of interest flourish. Physicians, professional organizations, and academic medical centers must continually evaluate their relationships with the pharmaceutica …
Health care in the United States is a tangled web of competing interest groups beneath which ethical conflicts of interest flourish. …
Origins of the Crisis in Insulin Affordability and Practical Advice for Clinicians on Using Human Insulin.
Curr Diab Rep. 2020 Jan 29;20(1):2. doi: 10.1007/s11892-020-1286-3.
Curr Diab Rep. 2020.
PMID: 31997036
Free PMC article.
Review.
PURPOSE OF REVIEW: High insulin prices and cost-related insulin underuse are increasingly common and vexing problems for healthcare providers. ...However, it is also important to support initiatives to advocate for affordable pricing for insulin for patients …
PURPOSE OF REVIEW: High insulin prices and cost-related insulin underuse are increasingly common and vexing problems for healt …
Cite